跳至主要内容
临床试验/NCT01906333
NCT01906333已完成不适用

Effects of Acute Elevation of Circulating Fatty Acids on Skeletal Muscle Lipid Accumulation and Metabolism in Healthy Lean Young Men

Maastricht University Medical Center1 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2013年5月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
12
试验地点
1
主要终点
Change in IntraMyoCellularLipid (IMCL)content

研究概览

简要总结

There is increasing evidence that skeletal muscle lipid content (IntraMyoCellular Lipid, IMCL) markedly increases the risk of metabolic complications, including insulin resistance and cardiovascular events. The investigator hypothesizes that skeletal muscle is passively taking up FFAs when the availability is high, thereby leading to an increased storage. To test this hypothesis, the investigator wants to manipulate FFA levels, by means of exercise, and monitor intramuscular lipid content.

Therefore the objective is to examine the effect of an exercise-induced elevation of FFA on skeletal muscle lipid content in healthy lean men. To this end, skeletal muscle lipid content will be investigated at baseline and after an exercise protocol and again after a four-hour recovery period from exercise, once in a condition with high FFA concentration, once with low FFA concentration. To achieve high- versus low FFA concentrations, an exercise protocol was chosen and participants had to perform this protocol once with a glucose supplementation and once without.

Skeletal muscle lipid content will be determined before, directly after exercise and 4 h post exercise (from muscle biopsies) with or without glucose supplementation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
盲法
None

入排标准

年龄范围
18 Years 至 30 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • Age 18-30 years
  • Lean, BMI 18-25 kg/m2
  • Stable dietary habits
  • No medication use

排除标准

  • Female sex
  • Engagement in programmed exercise > 2 hours total per week
  • Cardiac problems, such as angina pectoris, cardiac infarction and arrhythmias
  • First degree relatives with type 2 diabetes mellitus
  • Any medical condition requiring treatment and/or medication use
  • Unstable body weight (weight gain or loss > 3 kg in the past three months)
  • Participation in other biomedical study within 1 month prior to the screening visit
  • Subjetcs, who do not want to be informed about unexpected medical findings, or do not wish that their treating physician is informed, cannot participate in the study

结局指标

主要结局

Change in IntraMyoCellularLipid (IMCL)content

时间窗: Baseline, directly postexercise and 4 hours post-exercise

A muscle biopsy will be withdrawn before, after 2 hours of exercise and again 4 hours post-exercise for later analysis of IMCL.

次要结局

  • Change in substrate metabolism(Measured several time points during the test day)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Lena Bilet

PhD student

Maastricht University Medical Center

研究点 (1)

Loading locations...

相似试验